| 1 day | -2.19% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 2023-06-21 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 2022-06-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 2016-11-03 |
Peter Montour
BRD | Director/Board Member | - | 2021-08-29 |
William Montour
BRD | Director/Board Member | - | 2022-01-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.19% | +16.32% | - | - | 29.39M | ||
| +0.15% | -2.67% | +219.71% | -6.81% | 2.48B | ||
| +4.52% | +1.97% | +116.40% | +102.07% | 1.69B | ||
| +0.22% | -2.49% | -24.97% | +123.25% | 452M | ||
| 0.00% | -4.92% | +16.00% | -3.33% | 63.21M | ||
| Average | +0.54% | -1.63% | +81.78% | +53.79% | 1.17B | |
| Weighted average by Cap. | +1.71% | -0.99% | +156.13% | +45.03% |
Employees
-
Sector
Pharmaceuticals
















